Cargando…

185. Pseudomonas aeruginosa (PA) Bacteremia and Patient Outcome during COVID-19 Pandemic

BACKGROUND: Pseudomonas aeruginosa (PA) bloodstream infection is associated with poor clinical outcomes. The purpose of this study was to evaluate treatment efficacy and patient outcomes from different antimicrobials used for treating PA bacteremia during 2020-2022. METHODS: This was a retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vivekanandan, Renuga, Witherspoon, Kelsey, Destache, Christopher J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678226/ http://dx.doi.org/10.1093/ofid/ofad500.258

Ejemplares similares

2394. A Longitudinal Study of the Effect of Renal Failure on Readmission Rates of Patients with Clostridioides difficile
por: Destache, Christopher J, et al.
Publicado: (2019)

1195. Where You Live Matters: United States Region as a Significant Predictor of Mortality for ESBL Infection Based on a Descriptive Study Using NIS Database
por: George, Elizabeth, et al.
Publicado: (2018)

2095. Antimicrobial Stewardship (ASP) in Rural and Critical Access Hospitals (CAHs) Using TeleStewardship® Services
por: Ased, Sumaya J, et al.
Publicado: (2019)

1808. Matrix-Assisted Laser Desorption/Ionization-Time of Flight (MALDI-TOF) and Vitek 2 Along With Antimicrobial Stewardship (ASP) Result in Faster Antimicrobial Therapy for Infected Patients: The CHI Health Experience
por: Cavalieri, Stephen, et al.
Publicado: (2018)

861. Health Disparities in HIV and Pregnancy
por: Abbas, Anum, et al.
Publicado: (2018)

2691. Comparison of Incidence and Mortality of Kaposi’s Sarcoma Amongst Solid-Organ Transplant Recipients
por: Gummadi, Padma Priya, et al.
Publicado: (2019)

Improving understanding and utilization of the antibiogram among medical residents
por: Cooper, Stephen J., et al.
Publicado: (2022)

1069. Implementation and Results of a Health-System Antimicrobial Stewardship (AMS) Program
por: Boldt, Dayla, et al.
Publicado: (2019)

129. Beta-lactam vs Fluoroquinolone Monotherapy for pseudomonas Aeruginosa infection: A Systematic Review and Meta-analysis
por: Reid, Eric C, et al.
Publicado: (2020)

Trends in Pseudomonas aeruginosa (P. aeruginosa) Bacteremia during the COVID-19 Pandemic: A Systematic Review
por: Ng, Qin Xiang, et al.
Publicado: (2023)

185. Clinical Characterization of Staphylococcus aureus Bacteremia in Children at an Inner-City Community Hospital
por: Oommen, Jomi K, et al.
Publicado: (2019)

Breakthrough Bacteremia with Meropenem-resistant Pseudomonas aeruginosa in Hematologic Malignancy Patients Receiving Levofloxacin Prophylaxis
por: Hakki, Morgan, et al.
Publicado: (2017)

2281. Ceftolozane–tazobactam (C/T) Treatment Outcomes in Immunocompromised (IC) Patients with Multidrug-Resistant (MDR) Pseudomonas aeruginosa (PA) Infections
por: Hart, Delaney E, et al.
Publicado: (2019)

2164. Activity of Fosfomycin (FOF) and Frequency of Nonsusceptible Inner Colonies During Susceptibility Testing of an International Collection of Clinical Pseudomonas aeruginosa (PA) Isolates
por: Smith, Elizabeth C, et al.
Publicado: (2019)

Discharge disposition and clinical outcomes of patients hospitalized with COVID-19
por: Patel, Shiv, et al.
Publicado: (2023)

481. Evolution of Carbapenem-Resistant Pseudomonas aeruginosa (CR-PA) Genetic Lineages and Acquisition of β-Lactamase Enzymes
por: Sakurai, Aki, et al.
Publicado: (2019)

2278. Emergence of Resistance and Associated Mortality during Persistent Pseudomonas aeruginosa Bacteremia in Hematopoietic Cell Transplant Recipients and Hematologic Malignancy Patients
por: Fontana, Lauren, et al.
Publicado: (2019)

1596. Ceftolozane/tazobactam (Zerbaxa) for the Treatment of Pseudomonas aeruginosa (PSA) Bacteremia: A Systematic Literature Review (SLR)
por: Dillon, Ryan J, et al.
Publicado: (2020)

Aspergillus fumigatus (Af) Hydroxamate Siderophores Protect Formation of Af Biofilms from the Pseudomonas aeruginosa (Pa) Product Pyoverdine
por: Sass, Gabriele, et al.
Publicado: (2017)

2163. Prevalence and geographic distribution of mutations in TonB-dependent receptors in the Prospective Observational Pseudomonas aeruginosa (PA) Study
por: Egge, Stephanie, et al.
Publicado: (2023)

656. Development and Application of a Pragmatic Algorithm for the Detection of Carbapenemase-Producing Pseudomonas aeruginosa (CP-PA)
por: Gill, Christian M, et al.
Publicado: (2020)

COVID-19 Mortality and Therapeutics in Nebraska and Southwest Iowa during Early Pandemic
por: Destache, Christopher J., et al.
Publicado: (2022)

Clinical Predictors of Pseudomonas aeruginosa Bacteremia in Emergency Department
por: Choi, Yongsoon, et al.
Publicado: (2018)

Pseudomonas aeruginosa bacteremia among liver transplant recipients
por: Liu, Taohua, et al.
Publicado: (2018)

1580. Characteristics of Early vs. Late Onset Post-transplant Lymphoproliferative Disorder After Liver Transplant:– A Descriptive Study of the United Network of Organ Sharing (UNOS) Database
por: Wintheiser, Grant, et al.
Publicado: (2018)

185. Does an Infectious Diseases Consultation Improve Clinical Outcomes and Treatment Bundle Adherence for Enterococcal Bacteremia in a Multicenter Healthcare System?
por: Shephard, Emily A, et al.
Publicado: (2021)

2438. Ceftolozane/Tazobactam (C/T) Against Multidrug-Resistant Pseudomonas aeruginosa (MDR-Pa) Infections: Clinical Efficacy, and Baseline and Emergent Resistance
por: Shields, Ryan K, et al.
Publicado: (2018)

1107. Three Year Longitudinal Assessment of Pseudomonas aeruginosa (Pa) Antibiotic Susceptibility in Children with Cystic Fibrosis (CF) in the Era of Modulator Therapy
por: Bradley, John, et al.
Publicado: (2023)

Pseudomonas aeruginosa bacteremia in patients with liver cirrhosis: a comparison with bacteremia caused by Enterobacteriaceae
por: Bang, Ji Hwan, et al.
Publicado: (2013)

Crystal structure of the flavoenzyme PA4991 from Pseudomonas aeruginosa
por: Jacewicz, Agata, et al.
Publicado: (2016)

PA3297 Counteracts Antimicrobial Effects of Azithromycin in Pseudomonas aeruginosa
por: Tan, Hao, et al.
Publicado: (2016)

Strategies for improved rhamnolipid production by Pseudomonas aeruginosa PA1
por: Soares dos Santos, Alexandre, et al.
Publicado: (2016)

The Role of PaFicT in Pseudomonas aeruginosa Persister Cell Formation
por: Fogen, Dawson
Publicado: (2021)

2820. Clinical Outcomes in Patients Who Receive a One-Time Aminoglycoside Dose for ESBL Enterobacterales or Pseudomonas aeruginosa cystitis
por: Bouwman, Kelsey, et al.
Publicado: (2023)

Ceftolozane/Tazobactam Dosing Requirements Against Pseudomonas aeruginosa Bacteremia
por: Ruiz, Jesus, et al.
Publicado: (2020)

Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study
por: Babich, Tanya, et al.
Publicado: (2022)

Beta-Lactam vs. Fluoroquinolone Monotherapy for Pseudomonas aeruginosa Infection: A Systematic Review and Meta-Analysis
por: Reid, Eric, et al.
Publicado: (2021)

Implementation of a Health-System Wide Antimicrobial Stewardship Program in Omaha, NE
por: Anthone, Jennifer, et al.
Publicado: (2019)

In host evolution of beta lactam resistance during active treatment for Pseudomonas aeruginosa bacteremia
por: Spottiswoode, Natasha, et al.
Publicado: (2023)

Genome Sequences of Three Strains of the Pseudomonas aeruginosa PA7 Clade
por: Boukerb, Amine M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_de8ermj549pt4emdn4cso966q3